Rho GTPase signaling in the development of colorectal cancer

Journal of Cellular Biochemistry

Volumn 113, Issue 8, 2012, Pages 2549-2559

  Leve, Fernanda ^a   Morgado Díaz, José A ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

Actin cytoskeleton; Cell signaling; Cell cell adhesion; Colorectal cancer; Rho GTpases; Tumor progression

Indexed keywords

BEVACIZUMAB; CETUXIMAB; DOXORUBICIN; FASUDIL; FLUOROURACIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRINOTECAN; OXALIPLATIN; PROTEIN CDC42; RAC1 PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TEPRENONE;

ANTINEOPLASTIC ACTIVITY; BRAIN VASOSPASM; CANCER GROWTH; CANCER INVASION; CANCER RESISTANCE; CELL ADHESION; CELL INVASION; CELL LOSS; CELL PROLIFERATION; COLON CANCER; COLORECTAL CANCER; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL ADHESION; CELL MOVEMENT; COLORECTAL NEOPLASMS; CYTOSKELETON; HUMANS; RHO GTP-BINDING PROTEINS;

EID: 84862550404     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24153     Document Type: Review

References (110)

1. Akçakaya P, Ekelund S, Kolosenko I, Caramuta S, Özata DM, Xie H, Lindforss U, Olivecrona H, Lui WO. 2011. miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer. Internat J Oncol 39:311-318.
2. Ayaki M, Komatsu K, Mukai M, Murata K, Kameyama M, Ishiguro S, Miyoshi J, Tatsuta M, Nakamura H. 2001. Reduced expression of focal adhesion kinase in liver metastases compared with matched primary human colorectal adenocarcinomas. Clin Cancer Res 7:3106-3112. (Pubitemid 32963831)
3. Balda MS, Garret MD, Matter K. 2003. The ZO-1 associated Y-box factor ZONAB regulates epithelial cell proliferation and cell density. J Cell Biol 160:423-432. (Pubitemid 36182732)
4. Bellovin DI, Bates RC, Muzikansky A, Rimm DL, Mercurio AM. 2005. Altered Localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive disease. Cancer Res 65:10938-10945. (Pubitemid 41713362)
5. Bellovin DI, Simpson KJ, Danilov T, Maynard E, Rimm DL, Oettgen P, Mercurio AM. 2006. Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma. Oncogene 25:6959-6967. (Pubitemid 44684836)
6. Benitah SA, Valerón PF, van Aelst L, Marshall CJ, Lacal JC. 2004. Rho GTPases in human cancer: An unresolved link to upstream and downstream transcriptional regulation. Biochim Biophys Acta 1705:121-132. (Pubitemid 39592900)
7. Boulter E, Garcia-Mata R, Guilluy C, Dubash A, Rossi G, Brennwald PJ, Burridge K. 2010. Regulation of RhoGTPase crosstalk, degradation and activity by RhoGDI1. Nat cell Biol 12:477-483.
8. Boyer L, Turchi L, Desnues B, Doye A, Ponzio G, Mege JL, Yamashita M, Zhang YE, Bertoglio J, Flatau G, Boquet P, Lemichez E. 2006. CNF1-induced ubiquitylation and proteasome destruction of activated RhoA is impaired in smurf-/- cells. Mol Cel Biol 17:2489-2497. (Pubitemid 43825488)
9. Buchert M, Papin M, Bonnans C, Darido C, Raye WS, Garambois V, Pélegrin A, Bourgaux JF, Pannequin J, Joubert D, Hollande F. 2010. Symplekin promotes tumorigenicity by up-regulating claudin-2 expression. Proc Natl Acad Sci 107:2628-2633.
10. Carothers AM, Javid SH, Moran AE, Hunt DH, Redston M, Bertagnolli MM. 2006. Deficient E-cadherin adhesion in C57BL/6j-Min/+ mice is associated with increased tyrosine kinase activity and RhoA-dependent actomyosin contractility. Exp Cell Res 312:387-400. (Pubitemid 41805096)
11. Carter JH, Douglass LE, Deddens JA, Colligan BM, Bhatt TR, Pemberton JO, Konicek S, Hom J, Marshall M, Graff JR. 2004. Pak-1 expression increases with progression of colorectal carcinomas to metastasis. Clin Cancer Res 10:3448-3456. (Pubitemid 38685452)
12. Chen X, Halberg RB, Burch RP, Dove WF. 2008. Intestinal adenomagenesis involves core molecular signatures of the epithelial-mesenchymal transition. J Mol Histol 39:283-294.
13. Cheng KW, Agarwal R, Mills GB. 2009. Ras-superfamily GTPases in ovarian cancer. Cancer Treat Res 149:229-240.
14. Cho SJ, Kim JS, Kim JM, Lee JY, Jung HC, Son IS. 2008. Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice. Int J Cancer 123:951-957.
15. Croft DR, Sahai E, Mavria G, Li S, Tsai J, Lee WMF, Marshall CJ, Olson MF. 2004. Conditional ROCK activation in vivo induces tumor cell dissemination and angiogenesis. Cancer Res 64:8994-9001. (Pubitemid 39665509)
16. Cushman I, Casey PJ. 2011. RHO methylation matters: A role for isoprenylcysteine carboxylmethyltransferase in cell migration and adhesion. Cell Adhes Migr 5:11-15.
17. DerMardirossian C, Rocklin G, Seo JY, Bokoch GM. 2006. Phosphorylation of RhoGDI by Src regulates Rho GTPase binding and cytosol-membrane cycling. Mol Biol Cel 17:4760-4768. (Pubitemid 44665745)
18. Dise RS, Frey MR, Whitehead RH, Polk DB. 2008. Epidermal growth factor stimulates Rac activation through Src and phosphatidylinositol 3-kinase to promote colonic epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 294:G276-G285.
19. Doublier S, Riganti C, Voena C, Costamagna C, Aldieri E, Pescarmona G, Ghigo D, Bosia A. 2008. RhoA silencing reverts the resistance to doxorubicin in human colon cancer cells. Mol Cancer Res 6:1607-1620.
20. El-Bahrawy M, Talbot I, Poulsom R, Alison M. 2002. Variable nuclear localization of alpha-catenin in colorectal carcinoma. Lab Invest 82:1167-1174. (Pubitemid 35014850)
21. Espina C, Céspedes MV, García-Cabezas MA, Gomes Del Pulgar MT, Boluda A, Oroz LG, Cejas P, Nistal M, Mangues R, Lacal C. 2008. A critical role for Rac1 in tumor progression of human colorectal adenocarcinoma cells. Am J Pathol 172:156-166. (Pubitemid 351186377)
22. Esufali S, Charames GS, Pethe VV, Buongiorno P, Bapat B. 2007. Activation of tumor-specific splice variant Rac1b by disheveled promotes canonical Wnt signaling and decreased adhesion of colorectal cancer cells. Cancer Res 67:2469-2479. (Pubitemid 46548931)
23. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759-767.
24. Fujita A, Shida A, Fujioka S, Kurihara H, Okamoto T, Yanaga K. 2011. Clinical significance of Rho GDP dissociation inhibitor 2 in colorectal carcinoma. Int J Clin Oncol (in press) DOI: 10.1007/s10147-011-0270-y.
25. Gadéa G, Lapasset L, Gauthier-Rouviere C, Roux P. 2002. Regulation of Cdc42- mediated morphological effects: A novel function for p53. EMBO J 21:2373-2382. (Pubitemid 34546710)
26. Gadéa G, Toledo M, Anguille C, Roux P. 2007. Loss of p53 promotes RhoA-ROCK-dependent cell migration and invasion in 3D matrices. J Cell Biol 178:23-30. (Pubitemid 47026399)
27. Garcia-Mata R, Boulter E, Burridge K. 2011. The 'invisible hand': Regulation of RHO GTPases by RHOGDIs. Nat Rev Mol Cell Biol 12:493-504.
28. Gomes del Pulgar T, Bandrés E, Espina C, Valdés-Mora F, Peres-Palacios R, García-Amigot F, García-Foncillas J, Lacal JC. 2007. Differential expression of Rac1 identifies its target genes and its contribution to progression of colorectal cancer. Int J Biochem Cell Biol 39:2289-2302. (Pubitemid 47484283)
29. Gomes Del Pulgar T, Valdés-Mora F, Bandrés E, Pérez-Palacios R, Espina C, Cejas P, García-Cabezas MA, Nistal M, Casado E, González-Barón M, García-Foncillas J, Lacal JC. 2008. Cdc42 is highly expressed in colorectal adenocarcinoma and downregulates ID4 through an epigenetic mechanism. Int J Oncol 33:185-193.
30. Gong W, An Z, Wang Y, Pan X, Fang W, Jiang B, Zhang H. 2009. P21-activated kinase 5 is overexpressed during colorectal cancer progression and regulates colorectal carcinoma cell adhesion and migration. Int J Cancer 125:548-555.
31. Grise F, Bidaud A, Moreau V. 2009. Rho GTPases in hepatocellular carcinoma Biochim Biophys Acta 1795:137-151.
32. Guo F, Gao Y, Wang L, Zheng Y. 2003. p19Arf-p53 tumor suppressor pathway regulates cell motility by suppression of phosphoinositide 3-kinase and Rac1 GTPase activities. J Biol Chem 278:14414-144149.
33. Guo F, Liu Y, Huang J, Li Y, Zhou G, Wang D, Li Y, Wang J, Xie P, Li G. 2010. Identification of Rho GTPase activating protein 6 isoform 1 variant as a new molecular marker in human colorectal tumors. Pathol Oncol Res 16:319-326.
34. Guo F, Zheng Y. 2004. Rho family GTPases cooperate with p53 deletion to promote primary mouse embryonic fibroblast cell invasion. Oncogene 23:5577-5585. (Pubitemid 39093035)
35. Hlubek F, Brabletz T, Budczies J, PfeiVer S, Jung A, Kirchner T. 2007. Heterogeneous expression of Wnt/β-catenin target genes within colorectal cancer. Int J Cancer 121:1941-1948. (Pubitemid 47463156)
36. Hopkins AM, Walsh SV, Verkade P, Boquet P, Nusrat A. 2003. Constitutive activation of Rho proteins by CNF-1 influences tight junction structure and epithelial barrier function. J Cell Sci 116:725-742. (Pubitemid 36231311)
37. Iden S, Collard JG. 2008. Crosstalk between small GTPases and polarity proteins in cell polarization. Nat Rev Mol Cell Biol 9:846-859.
38. Ivanov AI, Samarin SN, Bachar M, Parkos CA, Nusrat A. 2009. Protein kinase C activation disrupts epithelial apical junctions via ROCK-II dependent stimulation of actomyosin contractility. BMC Cell Biol 10:36.
39. Iwaya K, Oikawa K, Semba S, Tsuchiya B, Mukai Y, Otsubo T, Nagao T, Izumi M, Kuroda M, Domoto H, Mukai K. 2007. Correlation between liver metastasis of the colocalization of actin-related protein 2 and 3 complex and WAVE2 in colorectal carcinoma. Cancer Sci 98:992-999. (Pubitemid 46865382)
40. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. 2006. Cancer statistics CA Cancer J Clin 56:106-130.
41. Jin H, Li T, Ding Y, Deng Y, Zhang W, Yang H, Zhou J, Liu C, Lin J, Ding Y. 2011. Methylation status of T-lymphoma invasion and metastasis 1 promoter and its overexpression in colorectal cancer. Hum Pathol 42:541-551.
42. Jin Y, Tian X, Shang Y, Huang P. 2008. Inhibition of DLC-1 gene expression by RNA interference in the colon cancer LoVo cell line. Oncol Rep 19:669-674. (Pubitemid 351330434)
43. Jo WS, Mizukami Y, Duerr EM, Zukerberg LR, Chung DC. 2005. Wnt signaling can repress thrombospondin-1 expression in colonic tumorigenesis. Cancer Biol Ther 4:1361-1366. (Pubitemid 43131181)
44. Johnstone CN, Castellví-Bel S, Chang LM, Bessa X, Nakagawa H, Harada H, Sung RK, Piqué JM, Castells A, Rustgi AK. 2004. ARHGAP8 is a novel member of the RHOGAP family related to ARHGAP1/CDC42GAP/p50RHO-GAP: Mutation and expression analyses in colorectal and breast cancers. Gene 336:59-71. (Pubitemid 38968825)
45. Jordan P, Brazao R, Boavida MG, Gespach C, Chastre E. 1999. Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors. Oncogene 18:6835-6839.
46. Kawasaki Y, Sato R, Akiyama T. 2003. Mutated APC and Asef are involved in the migration of colorectal tumour cells. Nat Cell Bio 5:211-215. (Pubitemid 36322247)
47. Kawasaki Y, Tsuji S, Muroya K, Furukawa S, Shibata Y, Okuno M, Ohwada S, Akiyama T. 2009. The adenomatous polyposis coli-associated exchange factors Asef and Asef2 are required for adenoma formation in Apc(Min/+) mice. EMBO Rep 10:1355-1362.
48. Kim TY, Vigil D, Der CJ, Juliano RL. 2009. Role of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motility. Cancer Metastasis Rev 28:77-83.
49. Lacopetta B. 2003. TP53 mutation in colorectal cancer. Hum Mutat 21:271-276.
50. Lee JE, Baba Y, Ng K, Giovannucci E, Fuchs CS, Ogino S, Chan AT. 2011. Statin use and volorectal cancer risk according to molecular subtypes in two large prospective cohort studies. Cancer Prev Res (Phila) 4:1808-1815.
51. Leve F, de Souza W, Morgado-Díaz JA. 2008. A cross-link between protein kinase A and Rho-family GTPases signaling mediates cell-cell adhesion and actin cytoskeleton organization in epithelial cancer cells. J Pharmacol Exp Ther 327:777-788.
52. Leve F, Marcondes TG, Bastos LG, Rabello SV, Tanaka MN, Morgado-Díaz JA. 2011. Lysophosphatidic acid induces a migratory phenotype through a crosstalk between RhoA-Rock and Src-FAK signalling in colon cancer cells. Eur J Pharmacol 671:7-17.
53. Li Y, Chen Y, Tao Y, Xu J, Chen M. 2010. RhoA protein is generally distributed in the nuclei of cancer cells. Oncol Rep 24:1005-1009.
54. Lin S, Wang D, Iyer S, Ghaleb AM, Shim H, Yang VW, Chun J, Yun CC. 2009. The absence of LPA2 attenuates tumor formation in an experimental model of colitis-associated cancer. Gastroenterol 136:1711-1720.
55. Liu M, Lang N, Chen X, Tang Q, Liu S, Huang J, Zheng Y, Bi F. 2011. MiR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells. Cancer Lett 301:151-160.
56. Liu Y, Xiao H, Tian Y, Nekrasova T, Hao X, Lee HJ, Suh N, Yang CS, Minden A. 2008. The pak4 protein kinase plays a key role in cell survival and tumorigenesis in athymic mice. Mol Cancer Res 6:1215-1224.
57. Lobell RB, Omer CA, Abrams MT, Bhimnathwala HG, Brucker MJ, Buser CA, Davide JP, deSolms SJ, Dinsmore CJ, Ellis-Hutchings MS, Kral AM, Liu D, Lumma WC, Machotka SV, Rands E, Williams TM, Graham SL, Hartman GD, Oliff AI, Heimbrook DC, Kohl NE. 2001. Evaluation of Farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models. Cancer Res 61:8758-8768. (Pubitemid 34013888)
58. Lozano E, Frasa MA, Smolarczyk K, Knaus UG, Braga VM. 2008. PAK is required for the disruption of E-cadherin adhesion by the small GTPase Rac. J Cell Sci 121:933-938. (Pubitemid 351639412)
59. Lynch EA, Stall J, Schmidt G, Chavrier P, D'Souza-Schorey C. 2006. Proteasome-mediated degradation of Rac1-GTP during epithelial cell scattering. Mol Biol Cell 17:2236-2242. (Pubitemid 44011739)
60. Makrodouli E, Oikonomou E, Koc M, Andera L, Sasazuki T, Shirasawa S, Pintzas A. 2011. BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: A comparative study. Mol Cancer 10:118.
61. Malliri A, Rygiel TP, van der Kammen RA, Song JY, Engers R, Hurlstone AF, Clevers H, Collard JG. 2006. The rac activator Tiam1 is a Wnt-responsive gene that modifies intestinal tumor development. J Biol Chem 281:543-548. (Pubitemid 43671217)
62. Matos P, Oliceira C, Velho S, Gonçalves V, da Costa LT, Moyer MP, Seruca R, Jordan P. 2008. B-RafV600E cooperates with alternative spliced Rac1b to sustain colorectal cancer cell survival. Gastroenterol 135:899-906.
63. Medici D, Hay ED, Goodenough DA. 2006. Cooperation between Snail and LEF-1 transcription factors is essential for TGF-β1-induced epithelial-mesenchymal transition. Mol Biol Cel 17:1871-1879. (Pubitemid 44011602)
64. Medley QG, Buchbinder EG, Tachibana K, Ngo H, Serra-Pagès C, Streuli M. 2003. Signaling between focal adhesion kinase and trio. J Biol Chem 278:13265-13270. (Pubitemid 36800096)
65. Minard ME, Ellis LM, Gallick GE. 2006. Tiam1 regulates cell adhesion, migration and apoptosis in colon tumor cells. Clin Exp Metastasis 23:301-313.
66. Minard ME, Herynk MH, Collard JG, Gallick GE. 2005. The guanine nucleotide exchange factor Tiam1 increases colon carcinoma growth at metastatic sites in an orthotopic nude mouse model. Oncogene 24:2568-2573. (Pubitemid 40593047)
67. Mitin N, Betts L, Yohe ME, Der CJ, Sondek J, Rossman KL. 2007. Release of autoinhibition of ASEF by APC leads to CDC42 activation and tumor suppression. Nat Struct Mol Biol 14:814-823. (Pubitemid 47373836)
68. Moore M, Marroquin BA, Gugliotta W, Tse R, White SR. 2004. Rho kinase inhibition initiates apoptosis in human airway epithelial cells. Am J Respir Cell Mol Biol 30:379-387. (Pubitemid 38315390)
69. Nabeshima R, Shimao Y, Inoue T, Koono M. 2002. Immunohistochemical analysis of IQGAP1 expression in human colorectal carcinomas: Its overexpression in carcinomas and association with invasion fronts. Cancer Lett 176:101-109. (Pubitemid 34085075)
70. Ng K, Ogino S, Meyerhardt JA, Chan JA, Chan AT, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Benson AB, Schaefer PL, Whittom R, Hantel A, Goldberg RM, Bertagnolli MM, Venook AP, Fuchs CS. 2011. Relationship between statin use and colon cancer recurrence and survival: Results from CALGB 89803. J Natl Cancer Inst 103:1540-1551.
71. Nomanbhoy TK, Cerione R. 1996. Characterization of the interaction between RhoGDI and Cdc42Hs using fluorescence spectroscopy. J Biol Chem 271:10004-10009. (Pubitemid 26131555)
72. Noritake J, Watanabe T, Sato K, Wang S, Kaibuchi K. 2005. IQGAP1: A key regulator of adhesion and migration. J Cell Sci 118:2085-2092. (Pubitemid 40872832)
73. Olson MF. 2008. Applications for ROCK kinase inhibition. Curr Opin Cell Biol 20:242-248.
74. Park SY, Lee JH, Ha M, Nam JW, Kim VN. 2008. miR-29 miRNAs activate p53 by targeting p85 and CDC42. Nat Struct Mol Biol 16:23-29.
75. Pertz O, Hodgson L, Klemke RL, Hahn KM. 2006. Spatiotemporal dynamics of RhoA activity in migrating cells. Nature 440:1069-1072.
76. Pollock CB, Shirasawa S, Sasazuki T, Kolch W, Dhillon AS. 2005. Oncogenic K-RAS is required to maintain changes in cytoskeletal organization, adhesion, and motility in colon cancer cells. Cancer Res 65:1244-1250. (Pubitemid 40270149)
77. Qiao J, Holian O, Lee BS, Huang F, Zhang J, Lum H. 2008. Phosphorylation of GTP dissociation inhibitor by PKA negatively regulates RhoA. Am J Physiol Cell Physiol 295:C1161-C1168. (Pubitemid 352790336)
78. Reid TS, Terry KL, Casey PJ, Beese LS. 2004. Crystallographic analysis of CaaX prenyltransferases complexed with substrates defines rules of protein substrate selectivity. J Mol Biol 343:417-433. (Pubitemid 39296875)
79. Roberts PJ, Mitin N, Keller PJ, Chenette EJ, Madigan JP, Currin RO, Cox AD, Wilson O, Kirschmeier P, Der CJ. 2008. Rho Family GTPase modification and dependence on CAAX motif-signaled posttranslational modification. J Biol Chem 283:25150-25163.
80. Rusovici R, Ghaleb A, Shim H, Yang VW, Yun CC. 2007. Lysophosphatidic acid prevents apoptosis of Caco-2 colon cancer cells via activation of mitogen-activated protein kinase and phosphorylation of Bad. Biochim Biophys Acta 1770:1194-1203. (Pubitemid 47002150)
81. Sahai E, Garcia-Medina R, Pouyssegur J, Vial E. 2007. Smurf1 regulates tumor cell plasticity and motility through degradation of RhoA leading to localized inhibition of contractility. J Cell Biol 176:35-42. (Pubitemid 46041678)
82. Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, Pinner S, Sahai E, Marshall CJ. 2008. Rac activation and inactivation control plasticity of tumor cell movement. Cell 135:510-523.
83. Sebti SM, Adjei AA. 2004. Farnesyltransferase inhibitors. Sem Oncol 31:28-39. (Pubitemid 38241018)
84. Shitashige M, Hirohashi S, Yamada T. 2008. Wnt signaling inside the nucleus. Cancer Sci 99:631-637. (Pubitemid 351448063)
85. Sudhaharan T, Goh WI, Sem KP, Lim KB, Bu W, Ahmed S. 2011. Rho GTPase Cdc42 is a direct interacting partner of adenomatous polyposis coli protein and can alter its cellular localization PLoS ONE 6:e16603.
86. Takami Y, Higashi M, Kumagai S, Kuo PC, Kawana H, Koda K, Miyazaki M, Harigaya K. 2008. The activity of RhoA is correlated with lymph node metastasis in human colorectal cancer. Dig Dis Sci 53:467-473. (Pubitemid 351170027)
87. Takayama T, Ohi M, Hayashi T, Miyanishi K, Nobuoka A, Nakajima T, Satoh T, Takimoto R, Kato J, Sakamaki A, Niitsu Y. 2001. Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis. Gastroenterol 121:599-611. (Pubitemid 32822575)
88. Tang Y, Olufemi L, Wang MT, Nie D. 2008. Role of Rho GTPases in breast cancer. Front Biosci 13:759-776. (Pubitemid 351599780)
89. Tatsuta M, Iishi H, Baba M, Uedo N, Ishihara R, Higashino K, Mukai M, Ishiguro S. 2005. Induction by lysophosphatidic acid of peritoneal and pleural metastases of intestinal cancers induced by azoxymethane in Wistar rats. Cancer Lett 219:137-145. (Pubitemid 40269476)
90. Ullmannova V, Popescu NC. 2006. Expression profile of the tumor suppressor genes DLC-1 and DLC-2 in solid tumors. Int J Oncol 29:1127-1132.
91. Van Aken E, De Wever O, Correia da Rocha AS, Mareel M. 2001. Defective E-cadherin/catenin complexes in human cancer. Virchows Arch 439:725-751. (Pubitemid 33141317)
92. van der Flier LG, Clevers H. 2009. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol 71:241-260.
93. Vega FM, Ridley AJ. 2008. Rho GTPases in cancer cell biology. FEBS Lett 582:2093-2101.
94. Vidal F, de Araujo WM, Cruz AL, Tanaka MN, Viola JP, Morgado-Díaz JA. 2011. Lithium reduces tumorigenic potential in response to EGF signaling in human colorectal cancer cells. Int J Oncol 38:1365-1373.
95. Vishnubhotla R, Sun S, Huq J, Bulic M, Ramesh A, Guzman G, Cho M, Glover SC. 2007. ROCK-II mediates colon cancer invasion via regulation of MMP-2 and MMP-13 at the site of invadopodia as revealed by multiphoton imaging. Lab Invest 87:1149-1158. (Pubitemid 47609026)
96. Wang HB, Liu XP, Liang J, Yang K, Sui AH, Liu YJ. 2009. Expression of RhoA and RhoC in colorectal carcinoma and its relations with clinicopathological parameters. Clin Chem Lab Med 47:811-817.
97. Watanabe T, Wang S, Noritake J, Sato K, Fukata M, Takefuji M, Nakagawa M, Izumi N, Akiyama T, Kaibuchi K. 2004. Interaction with IQGAP1 Links APC to Rac1, Cdc42, and actin filaments during cell polarization and migration. Dev Cell 7:871-883. (Pubitemid 39654731)
98. Watnick RS, Cheng YN, Ranarajan A, Ince TA, Weinberg RA. 2003. Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. Cancer Cell 3:219-231. (Pubitemid 37443878)
99. Weyant MJ, Carothers AM, Dannenberg AJ, Bertagnolli MM. 2001. (+)-Catechin inhibits intestinal tumor formation and suppresses focal adhesion kinase activation in the min/+ mouse. Cancer Res 61:118-125. (Pubitemid 32106650)
100. Winter-Vann AM, Baron RA, Wong W, dela cruz J, York JD, Gooden DM, Bergo MO, Young SG, Toone EJ, Casey PJ. 2005. A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells. PNAS 102:4336-4341. (Pubitemid 40397112)
101. Xia M, Land H. 2007. Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility. Nat Struct Mol Biol 14:215-223. (Pubitemid 46355577)
102. Xue Y, Bi F, Zhang X, Pan Y, Liu N, Zheng Y, Fan D. 2004. Inhibition of endothelial cell proliferation by targeting Rac1 GTPase with small interference RNA in tumor cells. Biochem Biophys Res Commun 320:1309-1315. (Pubitemid 38916686)
103. Yanagawa R, Furukawa Y, Tsunoda T, Kitahara O, Kameyama M, Murata K, Ishikawa O, Nakamura Y. 2001. Genome wide-screeningof genes showing altered expression in liver metastases of human colorectal cancers by cDNA microarray. Neoplasia 3:395-401. (Pubitemid 32988809)
104. Yang M, Zhong WW, Srivastava N, Slavin A, Yang J, Hoey T, An S. 2005. G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the b-catenin pathway. PNAS 102:6027-6032. (Pubitemid 40594249)
105. Ying H, Biroc SL, Li W-W, Alicke B, Xuan J-A, Pagila R, Ohashi Y, Okada T, Kamata Y, Dinter H. 2006. The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models. Mol Cancer Ther 5:2158-2164. (Pubitemid 44530451)
106. Yoshikawa N, Tsuno NH, Okaji Y, Kawai K, Shuno Y, Nagawa H, Oshima N, Takahashi K. 2010. Isoprenoid geranylgeranylacetone inhibits human colon cancer cells through induction of apoptosis and cell cycle arrest. Anticancer Drugs 21:850-860.
107. Yu H-G, Nam J-O, Miller NLG, Tanjoni I, Walsh C, Shi L, Kim L, Chen XL, Tomar A, Lim S-T, Schlaepfer DD. 2011. p190RhoGEF (Rgnef) promotes colon carcinoma tumor progression via interaction with focal adhesion kinase. Cancer Res 71:360-370.
108. Yu W, Shewan AM, Brakeman P, Eastburn DJ, Datta A, Bryant DM, Fan QW, Weiss WA, Zegers MM, Mostov KE. 2008. Involvement of RhoA, ROCK I and myosin II in inverted orientation of epithelial polarity. EMBO Rep 9:923-929.
109. Zhai J, Lin H, Nie Z, Wu J, Cañete-Soler R, Schlaepfer WW, Schlaepfer DD. 2003. Direct interaction of focal adhesion kinase with p190RhoGEF. J Biol Chem 278:24865-24873. (Pubitemid 37548645)
110. Zhao L, Wang H, Li J, Liu Y, Ding Y. 2008. Overexpression of Rho GDP-dissociation inhibitor alpha is associated with tumor progression and poor prognosis of colorectal cancer. J Proteome Res 7:3994-4003.